Powder: -20°C for 3 years | In solvent: -80°C for 1 year
trans-ACPD ((±)-trans-ACPD) 是代谢型受体激动剂,可促进钙离子活动及产生内向电流。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 375 | 现货 | ||
2 mg | ¥ 537 | 现货 | ||
5 mg | ¥ 822 | 现货 | ||
10 mg | ¥ 1,370 | 现货 | ||
25 mg | ¥ 2,730 | 现货 | ||
50 mg | ¥ 3,970 | 现货 | ||
100 mg | ¥ 5,860 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 589 | 现货 |
产品描述 | trans-ACPD ((±)-trans-ACPD) is an equimolecular mixture of (1S, 3R)- and (1R, 3S)-ACPD. trans-ACPD is a selective agonist of the mGluR (metabotropic glutamate receptor); active at the group I/II mGlu receptors (EC50: 2/15/23/800 μM, mGluR2/1/5/4). |
靶点活性 | mGluR4:800 μM(EC50), mGluR5:23μM(EC50), mGluR1:15μM(EC50), mGluR2:2μM(EC50) |
体外活性 | Excitatory amino acid (EAA) analogues activate receptors that are coupled to the increased hydrolysis of phosphoinositides (PIs). Hippocampal slices are prepared from neonatal rats (6-11 days old) to characterize the effects of EAA analogues on these receptors in these studies. The concentration of trans-ACPD required to evoke half-maximal stimulation (EC50 value) is 51 μM. DL-2-Amino-3-phosphonopropionate (DL-AP3) is also equipotent as an inhibitor of PI hydrolysis stimulated by ibotenate, quisqualate, and trans-ACPD (IC50 values are 480-850 μM)[2]. |
体内活性 | Intrathecal injection of NMDA, kainate, and trans-ACPD, TNF-α, or IL-1β causes significant (p<0.001) biting behaviour in mice compared to animals injected intrathecally with saline. In all groups, systemic pre-treatment with GM (100 mg/kg, i.p.) significantly (p<0.001) reduces the biting behaviour compared to mice treated with saline (10 mL/kg, i.p.). The greatest effect of GM is observed on the pro-inflammatory cytokines and NMDA, with the following inhibition percentages: TNF-α (92±7%), IL-1β (91±5%), NMDA (69±1%), and trans-ACPD (71±12%). On the contrary, at the same dose, GM has no significant effect on the kainate-mediated biting response[3]. |
别名 | Trans-(±)-ACP, 1-amino-1,3-dicarboxycyclopentane, (±)-trans-ACPD |
分子量 | 173.17 |
分子式 | C7H11NO4 |
CAS No. | 67684-64-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1eq. NaOH: 50 mM
H2O: 5 mM, Heating is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
1eq. NaOH / H2O | 1 mM | 5.7747 mL | 28.8734 mL | 57.7467 mL | 144.3668 mL |
5 mM | 1.1549 mL | 5.7747 mL | 11.5493 mL | 28.8734 mL | |
1eq. NaOH | 10 mM | 0.5775 mL | 2.8873 mL | 5.7747 mL | 14.4367 mL |
20 mM | 0.2887 mL | 1.4437 mL | 2.8873 mL | 7.2183 mL | |
50 mM | 0.1155 mL | 0.5775 mL | 1.1549 mL | 2.8873 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
trans-ACPD 67684-64-4 Neuroscience GluR Trans-(±)-ACP transACPD 1-amino-1,3-dicarboxycyclopentane Trans-ACP Metabotropic glutamate receptors (±)-trans-ACPD trans ACPD mGluR Inhibitor inhibit inhibitor